|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-15 20:50
Sentiment: Negative
TLDR BioNTech stock fell around 8% Friday after it ended a Phase 2 trial for mRNA cancer vaccine autogene cevumeran in colorectal cancer An independent safety board recommended stopping the trial early, citing futility and an imbalance in survival outcomes between treatment groups This is the second trial failure for autogene cevumeran in 2026, following [...] The post BioNTech (BNTX) Stock Drops 8% After Colorectal Cancer mRNA Vaccine Trial Terminated appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central